Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock;Pro-atriální natriuretický peptid u pacientů v sepsi, těžké sepsi a septickém šoku

Klinicka Biochemie a Metabolismus

Volumn 15, Issue 3, 2007, Pages 127-131

  Průcha, Miroslav ^a   Zazula, R ^b   Dubska L ^a   Sedlackova L ^a   Kavka, B ^c  

^a Nemocnice Na Homolce   (Czech Republic)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c Nemocnice Na Homolce   (Czech Republic)

Author keywords

Diagnostics; Pro atrial natriuretic peptide; Prognosis; Sepsis

Indexed keywords

EID: 78649938119     PISSN: 12107921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Argus, D. C., Linde-Zwirble, W. T., Lidicker, J. et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cista of care. Crit. Care Med., 2001, 29, p. 1303-1310.
2. Hotchkiss, R. S., Karl, I. E. The pathophysiology and treatment of sepsis. N. Engl. J. Med., 2003, 348, p. 138-150.
3. Černý, V., Novák, I., Šrámek, V. Prevalence těžké sepse v České republice - prospektivní multicentrická jednodenní studie. Anest. intenziv. Med., 2003, 14, p. 218-222.
4. Patočka, J. Natriuretické peptidy: 25 let historie. Bull. ČSBMB, 2005, 33, p. 48-52.
5. Jabor, A. Natriuretické peptidy. Anest. neodklad. Péče, 1999, 10, p. 147-150.
6. Hoffmann, U., Brueckmann, M., Bertsch, T. et al. Increased plasma levels of NT-proANP and NT- proBNP as markers of cardiac dysfunction in septic patients. Clin. Lab., 2005, 51, p. 373-379.
7. Ueda, S., Nishio, K., Akai, Y. et al. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock, 2006, 26, p.134-139. (Pubitemid 44162498)
8. Rudiger, A., Gasser, S., Fischler, M. et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock and acute heart failure. Crit. Care Med., 2006, 34, p. 2140-2144.
9. Hartemink, K. J., Groeneveld, A. B., de Grot, M. C. et al. Alpha - atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit. Care Med., 2001, 29, p. 80-87.
10. Castillo, J. R, Zagler, A., Carillo-Jimenez, R. et al. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int. J. Infect. Dis., 2004, 8, p. 271-274.
11. Bone, R. C., Balk, R. A., Cerra, F. B. et al. American College of Chest Physicians/Society of Critical Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of Innovative therapies in sepsis. Chest, 1992, 101, p. 1644-1655.
12. Vincent, J.-L., Gris, P., Coffernils, M. et al. Myocardial depression characterizes the fatal course of septic shock. Surgery, 1992, 111, p. 660-667.
13. Lewy, M. M., Fink, M. P., Marshall, J. C. et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med., 2003, 29, p. 530-538.
14. Morgenthaler, N. G., Struck, J., Crain, M. CH. et al. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit. Care, 2005, 9, p. R37-R45 .
15. Witthaut, R., Busch, Ch., Frauenberger, P. et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis - associated left ventricular dysfunction. Intensive Care Med., 2003, 29, p. 1696-1702.